AH Capital Management’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$161M Sell
782,934
-138,165
-15% -$27.4M 0.81% 4
2026
Q2
$173M Hold
921,099
– – 1.21% 3
2026
Q1
$89.6M Hold
921,099
– – 6.94% 4
2025
Q4
$73.4M Sell
921,099
-1,827,424
-66% -$120M 4.64% 4
2025
Q3
$128M Hold
2,748,523
– – 9.2% 3
2025
Q2
$101M Hold
2,748,523
– – 32.32% 1
2025
Q1
$97.2M Hold
2,748,523
– – 13.87% 3
2024
Q4
$120M Hold
2,748,523
– – 16.13% 3
2024
Q3
$125M Hold
2,748,523
– – 10.96% 3
2024
Q2
$107M Hold
2,748,523
– – 9.1% 5
2024
Q1
$88.6M Sell
2,748,523
-2,948,544
-52% -$87.4M 6.41% 5
2023
Q4
$163M Buy
+5,697,067
New +$137M 10.06% 4

Other funds holding RVMD

AH Capital Management's RVMD Position: Q3 2026 in Review

AH Capital Management reduced its Revolution Medicines (RVMD) stake by 15% in Q3 2026, selling an estimated $27.4M and leaving 782,934 shares worth $161M. The position accounts for 0.81% of the portfolio, ranked #4.

AH Capital Management first reported a position in RVMD in Q4 2023 and has held it in 12 quarters since. The position peaked at $173M in Q2 2026. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • AH Capital Management held 782,934 shares of Revolution Medicines worth $161M as of Q3 2026.
  • AH Capital Management sold 138,165 Revolution Medicines shares in Q3 2026, an estimated $27.4M.
  • Revolution Medicines made up 0.81% of AH Capital Management's portfolio in Q3 2026, its #4 holding.
  • AH Capital Management first reported a position in Revolution Medicines in Q4 2023 and has held it in 12 quarters since.
  • AH Capital Management's Revolution Medicines position peaked at $173M in Q2 2026.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on AH Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.